Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CNAC Saturn is a Dutch-registered subsidiary of the China National Agrochemical Corporation (CNAC), which is itself a unit of the state-owned enterprise ChemChina. The entity was primarily established as the acquisition vehicle for ChemChina's $43 billion takeover of the Swiss seeds and pesticides giant Syngenta in 2017. As a key holding company within the Syngenta Group structure, CNAC Saturn plays a critical role in the management of global agrochemical assets, focusing on crop protection products and seeds. Its operations are central to China's strategic efforts to enhance food security and modernize its agricultural biotechnology sector through the integration of advanced global R&D and manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CNAC Saturn.